Loading...

David Waters, MD

TitleProfessor
InstitutionUniversity of California San Francisco
DepartmentMedicine
AddressSFGH NH
Phone415-206-8320
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Barter PJ, Waters D. Variations in time to benefit among clinical trials of cholesterol-lowering drugs. J Clin Lipidol. 2018 Apr 21. PMID: 29779997.
      View in: PubMed
    2. Vallejo-Vaz AJ, Fayyad R, Boekholdt SM, Hovingh GK, Kastelein JJ, Melamed S, Barter P, Waters D, Ray KK. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the Treating to New Targets (TNT) Trial. Circulation. 2018 Apr 04. PMID: 29618599.
      View in: PubMed
    3. Waters D, Vogt L. Lipids, inflammation, and chronic kidney disease: a SHARP perspective. Kidney Int. 2018 Apr; 93(4):784-786. PMID: 29571452.
      View in: PubMed
    4. Ong KL, Waters D, Fayyad R, Vogt L, Melamed S, DeMicco DA, Rye KA, Barter PJ. Relationship of High-Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin. J Am Heart Assoc. 2018 Jan 22; 7(2). PMID: 29358194.
      View in: PubMed
    5. Waters D, Bangalore S, Fayyad R, DeMicco DA, Laskey R, Melamed S, Barter PJ. Visit-to-visit variability of lipid measurements as predictors of cardiovascular events. J Clin Lipidol. 2018 Mar - Apr; 12(2):356-366. PMID: 29310989.
      View in: PubMed
    6. Waters D. Are Cholesterol Treatment Targets a Deterrent to Optimal Lipid-Lowering Therapy? JAMA Cardiol. 2017 Dec 01; 2(12):1392-1393. PMID: 29117287.
      View in: PubMed
    7. Hsue PY, Waters D. Heart failure in persons living with HIV infection. Curr Opin HIV AIDS. 2017 Nov; 12(6):534-539. PMID: 28863015.
      View in: PubMed
    8. Arsenault BJ, Petrides F, Tabet F, Bao W, Hovingh GK, Boekholdt SM, Ramin-Mangata S, Meilhac O, DeMicco D, Rye KA, Waters D, Kastelein JJP, Barter P, Lambert G. Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk. J Clin Lipidol. 2018 Jan - Feb; 12(1):130-136. PMID: 29103916.
      View in: PubMed
    9. Waters D, Nattel S. Taking Hockey to Heart: Potential Coronary Risks of Watching Exciting Games. Can J Cardiol. 2017 Dec; 33(12):1517-1519. PMID: 28987522.
      View in: PubMed
    10. Rosenson RS, Larrey D, Waters D, Olsson AG. RE: Praluent (Alirocumab)-Induced Renal Injury. J Pharm Pract. 2018 Apr; 31(2):138-139. PMID: 28974137.
      View in: PubMed
    11. Waters D, Bangalore S. The Evolution of Myocardial Infarction: When the Truths We Hold To Be Self-Evident No Longer Have Evidence. Can J Cardiol. 2017 10; 33(10):1209-1211. PMID: 28822651.
      View in: PubMed
    12. Bangalore S, Messerli FH, Waters D. Body-Weight Fluctuations and Outcomes in Coronary Disease. N Engl J Med. 2017 07 06; 377(1):95-6. PMID: 28679098.
      View in: PubMed
    13. Waters D, Hsue PY. PCSK9 Inhibition to Reduce Cardiovascular Risk: Tempering Expectations. Circ Res. 2017 May 12; 120(10):1537-1539. PMID: 28495986.
      View in: PubMed
    14. Bangalore S, Fayyad R, Laskey R, DeMicco DA, Messerli FH, Waters D. Body-Weight Fluctuations and Outcomes in Coronary Disease. N Engl J Med. 2017 04 06; 376(14):1332-1340. PMID: 28379800.
      View in: PubMed
    15. Waters D. The Rise and Fall of Tuberculosis and Atherosclerosis: First There Is a Mountain…. Can J Cardiol. 2017 03; 33(3):295-297. PMID: 28081868.
      View in: PubMed
    16. Bangalore S, Fayyad R, Messerli FH, Laskey R, DeMicco DA, Kastelein JJ, Waters D. Relation of Variability of Low-Density Lipoprotein Cholesterol and Blood Pressure to Events in Patients With Previous Myocardial Infarction from the IDEAL Trial. Am J Cardiol. 2017 Feb 01; 119(3):379-387. PMID: 27939230.
      View in: PubMed
    17. Waters D, Boekholdt SM. An Evidence-Based Guide to Cholesterol-Lowering Guidelines. Can J Cardiol. 2017 Mar; 33(3):343-349. PMID: 28034582.
      View in: PubMed
    18. Kohli P, Knowles JW, Sarraju A, Waters D, Reaven G. Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (from the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trials). Am J Cardiol. 2016 Nov 01; 118(9):1275-1281. PMID: 27614854.
      View in: PubMed
    19. Yan P, Tan EK, Choo JC, Liew CF, Lau T, Waters D. Statin-centric versus low-density lipoprotein-centric approach for atherosclerotic cardiovascular disease prevention: a Singapore perspective. Singapore Med J. 2016 Jul; 57(7):360-7. PMID: 27439304; PMCID: PMC4958711.
    20. Azar RR, Kadri Z, Waters D. Performance Deficiencies in the Treatment of ST-Elevation Myocardial Infarction in Québec: "Tis But a Part We See, and Not a Whole". Can J Cardiol. 2016 11; 32(11):1294.e5-1294.e7. PMID: 27523273.
      View in: PubMed
    21. Arsenault BJ, Kohli P, Lambert G, DeMicco DA, Laskey R, Messig MM, Kastelein JJ, Waters D. Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients With Coronary Artery Disease (from the Treating to New Targets [TNT] Study). Am J Cardiol. 2016 Aug 15; 118(4):494-8. PMID: 27328952.
      View in: PubMed
    22. Waters D, Hsue PY, Bangalore S. PCSK9 Inhibitors for Statin Intolerance? JAMA. 2016 Apr 19; 315(15):1571-2. PMID: 27039138.
      View in: PubMed
    23. Waters D, Arsenault BJ. Predicting Prognosis in Acute Coronary Syndromes: Makeover Time for TIMI and GRACE? Can J Cardiol. 2016 11; 32(11):1290-1293. PMID: 27062237.
      View in: PubMed
    24. Bangalore S, Fayyad R, Kastelein JJ, Laskey R, Amarenco P, DeMicco DA, Waters D. 2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis? Am J Med. 2016 Apr; 129(4):384-91. PMID: 26551986.
      View in: PubMed
    25. Waters D, Chau KH. Tribulations of Recent Cardiology Trials, the Audacity of Hope, and HOPE-3. Can J Cardiol. 2016 Mar; 32(3):275-7. PMID: 26577896.
      View in: PubMed
    26. Setia S, Fung SS, Waters D. Doctors' knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore. Vasc Health Risk Manag. 2015; 11:303-10. PMID: 26082642; PMCID: PMC4461017.
    27. Waters D. LDL-cholesterol lowering and renal outcomes. Curr Opin Lipidol. 2015 Jun; 26(3):195-9. PMID: 25887677.
      View in: PubMed
    28. Waters D, Hsue PY. PCSK9 Inhibition to Lower LDL-Cholesterol and Reduce Cardiovascular Risk: Great Expectations. Circ Res. 2015 May 08; 116(10):1643-5. PMID: 25953922.
      View in: PubMed
    29. Preiss D, Campbell RT, Murray HM, Ford I, Packard CJ, Sattar N, Rahimi K, Colhoun HM, Waters D, LaRosa JC, Amarenco P, Pedersen TR, Tikkanen MJ, Koren MJ, Poulter NR, Sever PS, Ridker PM, MacFadyen JG, Solomon SD, Davis BR, Simpson LM, Nakamura H, Mizuno K, Marfisi RM, Marchioli R, Tognoni G, Athyros VG, Ray KK, Gotto AM, Clearfield MB, Downs JR, McMurray JJ. The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. Eur Heart J. 2015 Jun 21; 36(24):1536-46. PMID: 25802390; PMCID: PMC4769322.
    30. Kohli P, Waters D, Nemr R, Arsenault BJ, Messig M, DeMicco DA, Laskey R, Kastelein JJP. Risk of new-onset diabetes and cardiovascular risk reduction from high-dose statin therapy in pre-diabetics and non-pre-diabetics: an analysis from TNT and IDEAL. J Am Coll Cardiol. 2015 Feb 03; 65(4):402-404. PMID: 25634843.
      View in: PubMed
    31. Banerjee A, Waters D, Camacho OM, Minet E. Quantification of plasma microRNAs in a group of healthy smokers, ex-smokers and non-smokers and correlation to biomarkers of tobacco exposure. Biomarkers. 2015 Mar; 20(2):123-31. PMID: 25598229.
      View in: PubMed
    32. Boekholdt SM, Hovingh GK, Waters D, Grundy SM, Kastelein JJP. Reply: statin-induced low low-density lipoprotein cholesterol level: is lower better? J Am Coll Cardiol. 2015 Jan 06; 65(1):109. PMID: 25572522.
      View in: PubMed
    33. Arsenault BJ, Barter P, DeMicco DA, Bao W, Preston GM, LaRosa JC, Grundy SM, Deedwania P, Greten H, Wenger NK, Shepherd J, Waters D, Kastelein JJ. Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers. PLoS One. 2014; 9(12):e114519. PMID: 25531109; PMCID: PMC4273994.
    34. Hsue PY, Bittner VA, Betteridge J, Fayyad R, Laskey R, Wenger NK, Waters D. Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trials. Am J Cardiol. 2015 Feb 15; 115(4):447-53. PMID: 25637322.
      View in: PubMed
    35. Swerdlow DI, Preiss D, Kuchenbaecker KB, Holmes MV, Engmann JE, Shah T, Sofat R, Stender S, Johnson PC, Scott RA, Leusink M, Verweij N, Sharp SJ, Guo Y, Giambartolomei C, Chung C, Peasey A, Amuzu A, Li K, Palmen J, Howard P, Cooper JA, Drenos F, Li YR, Lowe G, Gallacher J, Stewart MC, Tzoulaki I, Buxbaum SG, van der A DL, Forouhi NG, Onland-Moret NC, van der Schouw YT, Schnabel RB, Hubacek JA, Kubinova R, Baceviciene M, Tamosiunas A, Pajak A, Topor-Madry R, Stepaniak U, Malyutina S, Baldassarre D, Sennblad B, Tremoli E, de Faire U, Veglia F, Ford I, Jukema JW, Westendorp RG, de Borst GJ, de Jong PA, Algra A, Spiering W, Maitland-van der Zee AH, Klungel OH, de Boer A, Doevendans PA, Eaton CB, Robinson JG, Duggan D. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet. 2015 Jan 24; 385(9965):351-61. PMID: 25262344.
      View in: PubMed
    36. Boekholdt SM, Hovingh GK, Mora S, Arsenault BJ, Amarenco P, Pedersen TR, LaRosa JC, Waters D, DeMicco DA, Simes RJ, Keech AC, Colquhoun D, Hitman GA, Betteridge DJ, Clearfield MB, Downs JR, Colhoun HM, Gotto AM, Ridker PM, Grundy SM, Kastelein JJ. Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials. J Am Coll Cardiol. 2014 Aug 05; 64(5):485-94. PMID: 25082583; PMCID: PMC4443441.
    37. Waters D. The past and future of heart institutes: having moved beyond the one-trick pony. Can J Cardiol. 2014 Dec; 30(12 Suppl):S478-82. PMID: 25284806.
      View in: PubMed
    38. Kohli P, Waters D. Looking for coronary disease in patients with atrial fibrillation. Can J Cardiol. 2014 Aug; 30(8):861-3. PMID: 24975191.
      View in: PubMed
    39. Tardif JC, Ballantyne CM, Barter P, Dasseux JL, Fayad ZA, Guertin MC, Kastelein JJ, Keyserling C, Klepp H, Koenig W, L'Allier PL, Lespérance J, Lüscher TF, Paolini JF, Tawakol A, Waters D. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial. Eur Heart J. 2014 Dec 07; 35(46):3277-86. PMID: 24780501; PMCID: PMC4258222.
    40. Bangalore S, Fayyad R, Hovingh GK, Laskey R, Vogt L, DeMicco DA, Waters D. Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials. Am J Cardiol. 2014 Jun 15; 113(12):2018-20. PMID: 24793673.
      View in: PubMed
    41. Ong KL, Waters D, Messig M, DeMicco DA, Rye KA, Barter PJ. Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the treating to new targets study). Am J Cardiol. 2014 May 15; 113(10):1593-8. PMID: 24666618.
      View in: PubMed
    42. Waters D, Azar RR. The curse of target lesion calcification: still active after all these years. J Am Coll Cardiol. 2014 May 13; 63(18):1855-6. PMID: 24561144.
      View in: PubMed
    43. Arsenault BJ, Boekholdt SM, Mora S, DeMicco DA, Bao W, Tardif JC, Amarenco P, Pedersen T, Barter P, Waters D. Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL). Am J Cardiol. 2014 Apr 15; 113(8):1378-82. PMID: 24582532.
      View in: PubMed
    44. Ong KL, Barter PJ, Waters D. Cardiovascular drugs that increase the risk of new-onset diabetes. Am Heart J. 2014 Apr; 167(4):421-8. PMID: 24655688.
      View in: PubMed
    45. Waters D. Meta-analyses of statin trials: clear benefit for primary prevention in the elderly. J Am Coll Cardiol. 2013 Dec 03; 62(22):2100-1. PMID: 23994398.
      View in: PubMed
    46. Waters D, Boekholdt SM, Pedersen TR. Reply: To PMID 23219296. J Am Coll Cardiol. 2013 May 07; 61(18):1934. PMID: 23500266.
      View in: PubMed
    47. Waters D, Ho JE, Boekholdt SM, DeMicco DA, Kastelein JJ, Messig M, Breazna A, Pedersen TR. Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes. J Am Coll Cardiol. 2013 Jan 15; 61(2):148-52. PMID: 23219296.
      View in: PubMed
    48. Waters D. Papering over the cracks: meta-analysis to define the role of percutaneous coronary intervention in patients with stable angina. Can J Cardiol. 2013 Apr; 29(4):411-4. PMID: 22985786.
      View in: PubMed
    49. Bittner V, Wenger NK, Waters D, DeMicco DA, Messig M, LaRosa JC. Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease. Am Heart J. 2012 Sep; 164(3):387-93. PMID: 22980306.
      View in: PubMed
    50. Santos RD, Waters D, Tarasenko L, Messig M, Jukema JW, Chiang CW, Ferrieres J, Foody JM. A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: the Lipid Treatment Assessment Project 2. Atherosclerosis. 2012 Sep; 224(1):150-3. PMID: 22818564.
      View in: PubMed
    51. Waters D. Utility of biomarkers and imaging in the development of drugs for the treatment of coronary atherosclerosis. Can J Cardiol. 2012 Nov-Dec; 28(6):687-92. PMID: 22626947.
      View in: PubMed
    52. Mora S, Wenger NK, Demicco DA, Breazna A, Boekholdt SM, Arsenault BJ, Deedwania P, Kastelein JJ, Waters D. Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study. Circulation. 2012 Apr 24; 125(16):1979-87. PMID: 22461416; PMCID: PMC3338158.
    53. Ho JE, Waters D, Kean A, Wilson DJ, Demicco DA, Breazna A, Wun CC, Deedwania PC, Khush KK. Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study). Am J Cardiol. 2012 Jun 15; 109(12):1761-6. PMID: 22459310; PMCID: PMC4454417.
    54. Rodriguez F, Santos RD, Messig M, Tarasenko L, Ferrières J, Jukema JW, Chiang CW, Waters D, Foody JM. Comparison of lipid profiles and attainment of lipid goals in patients <65 years versus patients =65 years (from the Lipid Treatment Assessment Project [L-TAP] 2). Am J Cardiol. 2012 Jun 15; 109(12):1738-42. PMID: 22440124.
      View in: PubMed
    55. Nicholls SJ, Cavender MA, Kastelein JJ, Schwartz G, Waters D, Rosenson RS, Bash D, Hislop C. Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial. Cardiovasc Drugs Ther. 2012 Feb; 26(1):71-5. PMID: 22109255.
      View in: PubMed
    56. Hsue PY, Ordovas K, Lee T, Reddy G, Gotway M, Schnell A, Ho JE, Selby V, Madden E, Martin JN, Deeks SG, Ganz P, Waters D. Carotid intima-media thickness among human immunodeficiency virus-infected patients without coronary calcium. Am J Cardiol. 2012 Mar 01; 109(5):742-7. PMID: 22169125; PMCID: PMC3640832.
    57. Arsenault BJ, Boekholdt SM, Hovingh GK, Hyde CL, DeMicco DA, Chatterjee A, Barter P, Deedwania P, Waters D, LaRosa JC, Pedersen TR, Kastelein JJ. The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies. Circ Cardiovasc Genet. 2012 Feb 01; 5(1):51-7. PMID: 22135385.
      View in: PubMed
    58. Frey P, Waters D. Tobacco smoke and cardiovascular risk: a call for continued efforts to reduce exposure. Curr Opin Cardiol. 2011 Sep; 26(5):424-8. PMID: 21730825.
      View in: PubMed
    59. Secemsky E, Lange D, Waters D, Goldschlager NF, Hsue PY. Hemodynamic and arrhythmogenic effects of cocaine in hypertensive individuals. J Clin Hypertens (Greenwich). 2011 Oct; 13(10):744-9. PMID: 21974762.
      View in: PubMed
    60. Barter PJ, Rye KA, Tardif JC, Waters D, Boekholdt SM, Breazna A, Kastelein JJ. Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial. Circulation. 2011 Aug 02; 124(5):555-62. PMID: 21804130.
      View in: PubMed
    61. Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters D, DeMicco DA, Barter P, Cannon CP, Sabatine MS, Braunwald E, Kastelein JJ, de Lemos JA, Blazing MA, Pedersen TR, Tikkanen MJ, Sattar N, Ray KK. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA. 2011 Jun 22; 305(24):2556-64. PMID: 21693744.
      View in: PubMed
    62. Waters D, Ho JE, DeMicco DA, Breazna A, Arsenault BJ, Wun CC, Kastelein JJ, Colhoun H, Barter P. Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials. J Am Coll Cardiol. 2011 Apr 05; 57(14):1535-45. PMID: 21453832.
      View in: PubMed
    63. Chiang CW, Santos RD, Waters D, Messig M, Tarasenko L, Jukema JW, Ferrières J, Foody J, Seung KB. Reaching C-reactive protein and low-density lipoprotein cholesterol goals in dyslipidemic patients (from the Lipid Treatment Assessment Project [L-TAP] 2). Am J Cardiol. 2011 Jun 01; 107(11):1639-43. PMID: 21440886.
      View in: PubMed
    64. Arsenault BJ, Barter P, DeMicco DA, Bao W, Preston GM, LaRosa JC, Grundy SM, Deedwania P, Greten H, Wenger NK, Shepherd J, Waters D, Kastelein JJ. Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers. J Am Coll Cardiol. 2011 Jan 04; 57(1):63-9. PMID: 21185503.
      View in: PubMed
    65. Frey P, Waters D, DeMicco DA, Breazna A, Samuels L, Pipe A, Wun CC, Benowitz NL. Impact of smoking on cardiovascular events in patients with coronary disease receiving contemporary medical therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] trials). Am J Cardiol. 2011 Jan 15; 107(2):145-50. PMID: 21129718.
      View in: PubMed
    66. Frey P, Waters D. Statins before stents: does an ounce of prevention improve outcomes? Can J Cardiol. 2010 Nov; 26(9):486-7. PMID: 21076722; PMCID: PMC2989355.
    67. Jukema JW, Chiang CW, Ferrières J, Santos RD, Verdejo J, Waters D, Messig M, Tarasenko L. Lipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2. Curr Med Res Opin. 2010 Nov; 26(11):2589-97. PMID: 20879831.
      View in: PubMed
    68. Rosenson RS, Hislop C, Elliott M, Stasiv Y, Goulder M, Waters D. Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients. J Am Coll Cardiol. 2010 Sep 28; 56(14):1079-88. PMID: 20863951.
      View in: PubMed
    69. van den Bogaard B, van den Born BJ, Fayyad R, Waters D, DeMicco DA, LaRosa JC, Kastelein JJ, Holme I. On-treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets study. Eur J Clin Invest. 2011 Feb; 41(2):134-42. PMID: 20868450.
      View in: PubMed
    70. Ho JE, Bittner V, Demicco DA, Breazna A, Deedwania PC, Waters D. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial). Am J Cardiol. 2010 Apr 01; 105(7):905-11. PMID: 20346304.
      View in: PubMed
    71. Waters D. Exploring new indications for statins beyond atherosclerosis: Successes and setbacks. J Cardiol. 2010 Mar; 55(2):155-62. PMID: 20206067.
      View in: PubMed
    72. Rosen VM, Taylor DC, Parekh H, Pandya A, Thompson D, Kuznik A, Waters D, Drummond M, Weinstein MC. Cost effectiveness of intensive lipid-lowering treatment for patients with congestive heart failure and coronary heart disease in the US. Pharmacoeconomics. 2010; 28(1):47-60. PMID: 20014876.
      View in: PubMed
    73. Santos RD, Waters D, Tarasenko L, Messig M, Jukema JW, Ferrières J, Verdejo J, Chiang CW. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2. Am Heart J. 2009 Nov; 158(5):860-6. PMID: 19853709.
      View in: PubMed
    74. Waters D, Ku I. Early statin therapy in acute coronary syndromes: the successful cycle of evidence, guidelines, and implementation. J Am Coll Cardiol. 2009 Oct 06; 54(15):1434-7. PMID: 19796736.
      View in: PubMed
    75. Heinonen T, Waters D, Libby P, Tardif JC. A winter's tale: report from the First Annual Canadian Biomarkers and Surrogate Endpoints Symposium. Can J Cardiol. 2009 Sep; 25(9):527-32. PMID: 19746243; PMCID: PMC2780899.
    76. Faergeman O, Holme I, Fayyad R, Bhatia S, Grundy SM, Kastelein JJ, LaRosa JC, Larsen ML, Lindahl C, Olsson AG, Tikkanen MJ, Waters D, Pedersen TR. Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease. Am J Cardiol. 2009 Aug 15; 104(4):459-63. PMID: 19660594.
      View in: PubMed
    77. Waters D, Brotons C, Chiang CW, Ferrières J, Foody J, Jukema JW, Santos RD, Verdejo J, Messig M, McPherson R, Seung KB, Tarasenko L. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals. Circulation. 2009 Jul 07; 120(1):28-34. PMID: 19546386.
      View in: PubMed
    78. Waters D. Clinical insights from the Treating to New Targets trial. Prog Cardiovasc Dis. 2009 May-Jun; 51(6):487-502. PMID: 19410683.
      View in: PubMed
    79. Mutungi G, Waters D, Ratliff J, Puglisi M, Clark RM, Volek JS, Fernandez ML. Eggs distinctly modulate plasma carotenoid and lipoprotein subclasses in adult men following a carbohydrate-restricted diet. J Nutr Biochem. 2010 Apr; 21(4):261-7. PMID: 19369056.
      View in: PubMed
    80. Rosenson RS, Hislop C, McConnell D, Elliott M, Stasiv Y, Wang N, Waters D. Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial. Lancet. 2009 Feb 21; 373(9664):649-58. PMID: 19231633.
      View in: PubMed
    81. Wohl DA, Waters D, Simpson RJ, Richard S, Schnell A, Napravnik S, Keys J, Eron JJ, Hsue P. Ezetimibe alone reduces low-density lipoprotein cholesterol in HIV-infected patients receiving combination antiretroviral therapy. Clin Infect Dis. 2008 Oct 15; 47(8):1105-8. PMID: 18781882.
      View in: PubMed
    82. Johnson C, Waters D, DeMicco DA, Breazna A, Bittner V, Greten H, Grundy SM, LaRosa JC. Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study). Am J Cardiol. 2008 Nov 15; 102(10):1312-7. PMID: 18993147.
      View in: PubMed
    83. Brown TM, Vaidya D, Rogers WJ, Waters D, Howard BV, Tardif JC, Bittner V. Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria? J Womens Health (Larchmt). 2008 Jun; 17(5):841-7. PMID: 18537485; PMCID: PMC2942788.
    84. Shah SJ, Waters D, Barter P, Kastelein JJ, Shepherd J, Wenger NK, DeMicco DA, Breazna A, LaRosa JC. Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery. J Am Coll Cardiol. 2008 May 20; 51(20):1938-43. PMID: 18482661.
      View in: PubMed
    85. Krauss RM, Mangravite LM, Smith JD, Medina MW, Wang D, Guo X, Rieder MJ, Simon JA, Hulley SB, Waters D, Saad M, Williams PT, Taylor KD, Yang H, Nickerson DA, Rotter JI. Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment. Circulation. 2008 Mar 25; 117(12):1537-44. PMID: 18332269.
      View in: PubMed
    86. Jones RW, Kivipelto M, Feldman H, Sparks L, Doody R, Waters D, Hey-Hadavi J, Breazna A, Schindler RJ, Ramos H. The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics. Alzheimers Dement. 2008 Mar; 4(2):145-53. PMID: 18631958.
      View in: PubMed
    87. Vora AN, Ouyang P, Bittner V, Tardif JC, Waters D, Vaidya D. Racial differences of lipoprotein subclass distributions in postmenopausal women. Ethn Dis. 2008; 18(2):176-80. PMID: 18507270.
      View in: PubMed
    88. DeFaria Yeh D, Waters D. Preventing and treating stroke and transient ischemic attack. Am J Cardiol. 2008 Jan 15; 101(2):270-3. PMID: 18178421.
      View in: PubMed
    89. Kinlay S, Schwartz GG, Olsson AG, Rifai N, Szarek M, Waters D, Libby P, Ganz P. Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study. Arterioscler Thromb Vasc Biol. 2008 Jan; 28(1):142-7. PMID: 17991875.
      View in: PubMed
    90. Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters D, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med. 2007 Nov 22; 357(21):2109-22. PMID: 17984165.
      View in: PubMed
    91. Moran A, Simon JA, Shiboski S, Pickering TG, Waters D, Rotter JI, Lyon C, Nickerson D, Yang H, Saad M, Hsueh W, Krauss RM. Differential effects of ramipril on ambulatory blood pressure in African Americans and Caucasians. Am J Hypertens. 2007 Aug; 20(8):884-91. PMID: 17679038.
      View in: PubMed
    92. Waters D, Clark RM, Greene CM, Contois JH, Fernandez ML. Change in plasma lutein after egg consumption is positively associated with plasma cholesterol and lipoprotein size but negatively correlated with body size in postmenopausal women. J Nutr. 2007 Apr; 137(4):959-63. PMID: 17374661.
      View in: PubMed
    93. Yeboah J, Reboussin DM, Waters D, Kowalchuk G, Herrington DM. Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease. Am Heart J. 2007 Mar; 153(3):439-44. PMID: 17307425.
      View in: PubMed
    94. Hsue PY, McManus D, Selby V, Ren X, Pillutla P, Younes N, Goldschlager N, Waters D. Cardiac arrest in patients who smoke crack cocaine. Am J Cardiol. 2007 Mar 15; 99(6):822-4. PMID: 17350374.
      View in: PubMed
    95. Khush KK, Waters D, Bittner V, Deedwania PC, Kastelein JJ, Lewis SJ, Wenger NK. Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study. Circulation. 2007 Feb 06; 115(5):576-83. PMID: 17261662.
      View in: PubMed
    96. DeFaria Yeh D, Waters D. The SPARCL study: extending the indications of statin therapy for stroke? Nat Clin Pract Cardiovasc Med. 2007 Mar; 4(3):128-9. PMID: 17245322.
      View in: PubMed
    97. Marcus GM, Cohen J, Varosy PD, Vessey J, Rose E, Massie BM, Chatterjee K, Waters D. The utility of gestures in patients with chest discomfort. Am J Med. 2007 Jan; 120(1):83-9. PMID: 17208083.
      View in: PubMed
    98. Hsue PY, Hunt PW, Sinclair E, Bredt B, Franklin A, Killian M, Hoh R, Martin JN, McCune JM, Waters D, Deeks SG. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS. 2006 Nov 28; 20(18):2275-83. PMID: 17117013.
      View in: PubMed
    99. Friedewald VE, McPherson R, Roberts R, Roberts WC, Waters D. Statin therapy in acute coronary syndrome. Am J Cardiol. 2007 Jan 15; 99(2):213-21. PMID: 17223421.
      View in: PubMed
    100. Waters D, LaRosa JC, Barter P, Fruchart JC, Gotto AM, Carter R, Breazna A, Kastelein JJ, Grundy SM. Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study. J Am Coll Cardiol. 2006 Nov 07; 48(9):1793-9. PMID: 17084252.
      View in: PubMed
    101. Khush KK, Waters D. Effects of statin therapy on the development and progression of heart failure: mechanisms and clinical trials. J Card Fail. 2006 Oct; 12(8):664-74. PMID: 17045188.
      View in: PubMed
    102. Deedwania P, Barter P, Carmena R, Fruchart JC, Grundy SM, Haffner S, Kastelein JJ, LaRosa JC, Schachner H, Shepherd J, Waters D. Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. Lancet. 2006 Sep 09; 368(9539):919-28. PMID: 16962881.
      View in: PubMed
    103. Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart JC, Haffner S, Hsia J, Breazna A, LaRosa J, Grundy S, Waters D. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study. Diabetes Care. 2006 Jun; 29(6):1220-6. PMID: 16731999.
      View in: PubMed
    104. Waters D. What the statin trials have taught us. Am J Cardiol. 2006 Jul 01; 98(1):129-34. PMID: 16784935.
      View in: PubMed
    105. Herron KL, McGrane MM, Waters D, Lofgren IE, Clark RM, Ordovas JM, Fernandez ML. The ABCG5 polymorphism contributes to individual responses to dietary cholesterol and carotenoids in eggs. J Nutr. 2006 May; 136(5):1161-5. PMID: 16614398.
      View in: PubMed
    106. Nissen SE, Tuzcu EM, Brewer HB, Sipahi I, Nicholls SJ, Ganz P, Schoenhagen P, Waters D, Pepine CJ, Crowe TD, Davidson MH, Deanfield JE, Wisniewski LM, Hanyok JJ, Kassalow LM. Effect of ACAT inhibition on the progression of coronary atherosclerosis. N Engl J Med. 2006 Mar 23; 354(12):1253-63. PMID: 16554527.
      View in: PubMed
    107. Clark RM, Herron KL, Waters D, Fernandez ML. Hypo- and hyperresponse to egg cholesterol predicts plasma lutein and beta-carotene concentrations in men and women. J Nutr. 2006 Mar; 136(3):601-7. PMID: 16484531.
      View in: PubMed
    108. Simon JA, Lin F, Hulley SB, Blanche PJ, Waters D, Shiboski S, Rotter JI, Nickerson DA, Yang H, Saad M, Krauss RM. Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am J Cardiol. 2006 Mar 15; 97(6):843-50. PMID: 16516587.
      View in: PubMed
    109. Greene CM, Waters D, Clark RM, Contois JH, Fernandez ML. Plasma LDL and HDL characteristics and carotenoid content are positively influenced by egg consumption in an elderly population. Nutr Metab (Lond). 2006 Jan 06; 3:6. PMID: 16398934; PMCID: PMC1386675.
    110. Hsue PY, Waters D. What a cardiologist needs to know about patients with human immunodeficiency virus infection. Circulation. 2005 Dec 20; 112(25):3947-57. PMID: 16365213.
      View in: PubMed
    111. Khush KK, Rapaport E, Waters D. The history of the coronary care unit. Can J Cardiol. 2005 Oct; 21(12):1041-5. PMID: 16234887.
      View in: PubMed
    112. Waters D. Safety of high-dose atorvastatin therapy. Am J Cardiol. 2005 Sep 05; 96(5A):69F-75F. PMID: 16126026.
      View in: PubMed
    113. McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, Simon J, Krauss RM. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005 Aug 01; 96(3):399-404. PMID: 16054467.
      View in: PubMed
    114. Ruo B, Tripputi MT, Hsue PY, Saigo M, Ouyang P, Waters D. Usefulness of serum endothelin levels in predicting death and myocardial infarction but not coronary progression in postmenopausal women with coronary disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study). Am J Cardiol. 2005 Aug 01; 96(3):335-8. PMID: 16054453.
      View in: PubMed
    115. Olsson AG, Schwartz GG, Szarek M, Sasiela WJ, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A. High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial. Eur Heart J. 2005 May; 26(9):890-6. PMID: 15764620.
      View in: PubMed
    116. LaRosa JC, Grundy SM, Waters D, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005 Apr 07; 352(14):1425-35. PMID: 15755765.
      View in: PubMed
    117. Liu C, Waters D. Chlamydia pneumoniae and atherosclerosis: from Koch postulates to clinical trials. Prog Cardiovasc Dis. 2005 Jan-Feb; 47(4):230-9. PMID: 15991152.
      View in: PubMed
    118. Kelemen M, Vaidya D, Waters D, Howard BV, Cobb F, Younes N, Tripputti M, Ouyang P. Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women's Angiographic Vitamin and Estrogen (WAVE) trial. Atherosclerosis. 2005 Mar; 179(1):193-200. PMID: 15721027.
      View in: PubMed
    119. Saigo M, Waters D, Abe S, Biro S, Minagoe S, Maruyama I, Tei C. Soluble fibrin, C-reactive protein, fibrinogen, factor VII, antithrombin, proteins C and S, tissue factor, D-dimer, and prothrombin fragment 1 + 2 in men with acute myocardial infarction
      View in: PubMed
    120. Nair GV, Waters D, Rogers W, Kowalchuk GJ, Stuckey TD, Herrington DM. Pulse pressure and coronary atherosclerosis progression in postmenopausal women. Hypertension. 2005 Jan; 45(1):53-7. PMID: 15545509.
      View in: PubMed
    121. Khush KK, Waters D. Lessons from the PROVE-IT trial. Higher dose of potent statin better for high-risk patients. Cleve Clin J Med. 2004 Aug; 71(8):609-16. PMID: 15449756.
      View in: PubMed
    122. Howard BV, Hsia J, Ouyang P, Van Voorhees L, Lindsay J, Silverman A, Alderman EL, Tripputi M, Waters D. Postmenopausal hormone therapy is associated with atherosclerosis progression in women with abnormal glucose tolerance. Circulation. 2004 Jul 13; 110(2):201-6. PMID: 15226212.
      View in: PubMed
    123. Saigo M, Hsue PY, Waters D. Role of thrombotic and fibrinolytic factors in acute coronary syndromes. Prog Cardiovasc Dis. 2004 May-Jun; 46(6):524-38. PMID: 15224258.
      View in: PubMed
    124. Hsue PY, Lo JC, Franklin A, Bolger AF, Martin JN, Deeks SG, Waters D. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation. 2004 Apr 06; 109(13):1603-8. PMID: 15023877.
      View in: PubMed
    125. Waters D, Gordon D, Rossouw JE, Cannon RO, Collins P, Herrington DM, Hsia J, Langer R, Mosca L, Ouyang P, Sopko G, Stefanick ML. Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002 : Section 4: lessons from hormone replacement trials. Circulation. 2004 Feb 17; 109(6):e53-5. PMID: 14970126.
      View in: PubMed
    126. Bairey Merz N, Bonow RO, Sopko G, Balaban RS, Cannon RO, Gordon D, Hand MM, Hayes SN, Lewis JF, Long T, Manolio TA, Maseri A, Nabel EG, Desvigne Nickens P, Pepine CJ, Redberg RF, Rossouw JE, Selker HP, Shaw LJ, Waters D. Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: executive summary. Circulation. 2004 Feb 17; 109(6):805-7. PMID: 14970120.
      View in: PubMed
    127. Waters D, Guyton JR, Herrington DM, McGowan MP, Wenger NK, Shear C. Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit? Am J Cardiol. 2004 Jan 15; 93(2):154-8. PMID: 14715339.
      View in: PubMed
    128. Hsue PY, Giri K, Erickson S, MacGregor JS, Younes N, Shergill A, Waters D. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation. 2004 Jan 27; 109(3):316-9. PMID: 14718406.
      View in: PubMed
    129. Schwartz GG, Ganz P, Waters D, Arikian S. Pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. Am J Cardiol. 2003 Nov 01; 92(9):1109-12. PMID: 14583367.
      View in: PubMed
    130. Waters D. Statins and safety: applying the results of randomized trials to clinical practice. Am J Cardiol. 2003 Sep 15; 92(6):692-5. PMID: 12972108.
      View in: PubMed
    131. Jha AK, Varosy PD, Kanaya AM, Hunninghake DB, Hlatky MA, Waters D, Furberg CD, Shlipak MG. Differences in medical care and disease outcomes among black and white women with heart disease. Circulation. 2003 Sep 02; 108(9):1089-94. PMID: 12939228.
      View in: PubMed
    132. Metz L, Waters D. Implications of cigarette smoking for the management of patients with acute coronary syndromes. Prog Cardiovasc Dis. 2003 Jul-Aug; 46(1):1-9. PMID: 12920697.
      View in: PubMed
    133. Fram DB, Azar RR, Ahlberg AW, Gillam LD, Mitchel JF, Kiernan FJ, Hirst JA, Mather JF, Ficaro E, Cyr G, Waters D, Heller GV. Duration of abnormal SPECT myocardial perfusion imaging following resolution of acute ischemia: an angioplasty model. J Am Coll Cardiol. 2003 Feb 05; 41(3):452-9. PMID: 12575975.
      View in: PubMed
    134. Mostaghel E, Waters D. Women do benefit from lipid lowering: latest clinical trial data. Cardiol Rev. 2003 Jan-Feb; 11(1):4-12. PMID: 12493130.
      View in: PubMed
    135. Hong H, Aksenov S, Guan X, Fallon JT, Waters D, Chen C. Remodeling of small intramyocardial coronary arteries distal to a severe epicardial coronary artery stenosis. Arterioscler Thromb Vasc Biol. 2002 Dec 01; 22(12):2059-65. PMID: 12482835.
      View in: PubMed
    136. Hsia J, Alderman EL, Verter JI, Rogers WJ, Thompson P, Howard BV, Cobb FR, Ouyang P, Tardif JC, Higginson L, Bittner V, Barofsky I, Steffes M, Gordon DJ, Proschan M, Younes N, Waters D. Women's angiographic vitamin and estrogen trial: design and methods. Control Clin Trials. 2002 Dec; 23(6):708-27. PMID: 12505248.
      View in: PubMed
    137. Waters D, Alderman EL, Hsia J, Howard BV, Cobb FR, Rogers WJ, Ouyang P, Thompson P, Tardif JC, Higginson L, Bittner V, Steffes M, Gordon DJ, Proschan M, Younes N, Verter JI. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA. 2002 Nov 20; 288(19):2432-40. PMID: 12435256.
      View in: PubMed
    138. Waters D, Schwartz GG, Olsson AG, Zeiher A, Oliver MF, Ganz P, Ezekowitz M, Chaitman BR, Leslie SJ, Stern T. Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy. Circulation. 2002 Sep 24; 106(13):1690-5. PMID: 12270864.
      View in: PubMed
    139. Ansell BJ, Waters D. Reassessment of National Cholesterol Education Program Adult Treatment Panel-III guidelines: one year later. Am J Cardiol. 2002 Sep 01; 90(5):524-5. PMID: 12208415.
      View in: PubMed
    140. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002 Jul 03; 288(1):49-57. PMID: 12090862.
      View in: PubMed
    141. Gemayel C, Waters D. Mechanical or metabolic treatment for coronary disease: synergistic, not antagonistic, approaches. Cardiol Rev. 2002 May-Jun; 10(3):182-7. PMID: 12047796.
      View in: PubMed
    142. Hsue PY, Salinas CL, Bolger AF, Benowitz NL, Waters D. Acute aortic dissection related to crack cocaine. Circulation. 2002 Apr 02; 105(13):1592-5. PMID: 11927528.
      View in: PubMed
    143. Thompson PD, Moyna NM, White CM, Weber KM, Giri S, Waters D. The effects of hydroxy-methyl-glutaryl co-enzyme A reductase inhibitors on platelet thrombus formation. Atherosclerosis. 2002 Apr; 161(2):301-6. PMID: 11888512.
      View in: PubMed
    144. Waters D. Estrogen therapy for unstable angina: another bump for the bandwagon. J Am Coll Cardiol. 2002 Jan 16; 39(2):238-40. PMID: 11788213.
      View in: PubMed
    145. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, Borges-Neto S, Berman DS, Waters D, Heller GV. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation. 2002 Jan 01; 105(1):32-40. PMID: 11772873.
      View in: PubMed
    146. Waters D, Schwartz GG, Olsson AG. The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) trial: a new frontier for statins? Curr Control Trials Cardiovasc Med. 2001; 2(3):111-114. PMID: 11806782.
      View in: PubMed